24 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
20
Design, Synthesis, and Biological Evaluation of Coupled Bioactive Scaffolds as Potential Anticancer Agents for Dual Targeting of Dihydrofolate Reductase and Thioredoxin Reductase.

National University of Singapore
35
Inhibition of thioredoxin reductase by a novel series of bis-1,2-benzisoselenazol-3(2H)-ones: Organoselenium compounds for cancer therapy.

Peking University
1
Emerging protein targets for anticancer metallodrugs: inhibition of thioredoxin reductase and cathepsin B by antitumor ruthenium(II)-arene compounds.

University of Florence
13
Hypericins and thioredoxin reductase: Biochemical and docking studies disclose the molecular basis for effective inhibition by naphthodianthrones.

University of Padova
4
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.

University of California Santa Cruz
32
Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasis.

National Human Genome Research Institute
1
Interactions of methylene blue with human disulfide reductases and their orthologues from Plasmodium falciparum.

Biochemie-Zentrum Der Universit£T Heidelberg
3
NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family.

Johann Wolfgang Goethe University
19
Synthesis, cytotoxicity, antioxidant activity and molecular modeling of new NSAIDs-EBS derivatives.

Jianghan University
12
Discovery of novel hydroxyamidine based indoleamine 2,3-dioxygenase 1 (IDO1) and thioredoxin reductase 1 (TrxR1) dual inhibitors.

Wannan Medical College
5
Beyond direct Nrf2 activation; reinvestigating 1,2,4-oxadiazole scaffold as a master key unlocking the antioxidant cellular machinery for cancer therapy.

Alexandria University
8
Further exploration of DVD-445 as a lead thioredoxin reductase (TrxR) inhibitor for cancer therapy: Optimization of potency and evaluation of anticancer potential.

University of Belgrade
5
Piperlonguminine and Piperine Analogues as TrxR Inhibitors that Promote ROS and Autophagy and Regulate p38 and Akt/mTOR Signaling.

Nantong University
14
Novel electrophilic amides amenable by the Ugi reaction perturb thioredoxin system via thioredoxin reductase 1 (TrxR1) inhibition: Identification of DVD-445 as a new lead compound for anticancer therapy.

University of Belgrade
1
Novel curcumin analogue hybrids: Synthesis and anticancer activity.

Anhui Medical University
1
Manumycin A Is a Potent Inhibitor of Mammalian Thioredoxin Reductase-1 (TrxR-1).

Florida International University
1
Synthesis of naphthazarin derivatives and identification of novel thioredoxin reductase inhibitor as potential anticancer agent.

Lanzhou University
22
RAS INHIBITORS, COMPOSITIONS AND METHODS OF USE THEREOF

Genetolead
302
Substituted 6-azabenzimidazole compounds

Gilead Sciences
42
Inhibitors of dihydroceramide desaturase for treating disease

Centaurus Therapeutics
44
Substituted Bicyclic Heteroaryl Sulfonamide Derivatives for the Treatment of Cancer

Nodus Oncology
150
Class of isoindolone-imide ring-1,3-dione-2-ene compounds, composition and use thereof

Wigen Biomedicine Technology (Shanghai)
16
BIMT 17, a 5-HT2A receptor antagonist and 5-HT1A receptor full agonist in rat cerebral cortex.

Boehringer Ingelheim Italia